收藏切换
Research progresses of small molecule inhibitors targeting TGF-β and its receptors
收藏切换
PDF
Xiao-hong SANG1, Hao WANG2, Xue-fu YOU1, Xin-yi YANG1, *
Acta Pharmaceutica Sinica | 2019, 54(9) : 1538 - 1546
Less
收藏切换
Acta Pharmaceutica Sinica | 2019, 54(9): 1538-1546
Reviews
Research progresses of small molecule inhibitors targeting TGF-β and its receptors
Full
Xiao-hong SANG1, Hao WANG2, Xue-fu YOU1, Xin-yi YANG1, *
Affiliations
  • 1. Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • 2. School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China
Published: 2019-09-12 doi: 10.16438/j.0513-4870.2019-0132
Outline
收藏切换

Transforming growth factor-β (TGF-β) belongs to a group of biologically active cytokines that bind to its receptors to activate Smad signaling and non-Smad signaling pathways. The biological functions of TGF-β include promoting cell epithelial-mesenchymal transition, tissue fibrosis, angiogenesis and tumor immune evasion, as well as dual effects of cancer suppression and cancer promotion. Given the fact that the ligand-and receptors-mediated abnormal activation of TGF-β signaling pathways play an important role in the pathogenesis of multiple diseases such as malignant tumors and tissue fibrosis, more than a dozen small-molecule inhibitors have been developed to block the TGF-β signaling pathways, providing a novel method for controlling the development of these diseases. At present, pirfenidone, an inhibitor for TGF-β production, has been approved for treatment of idiopathic pulmonary fibrosis, while the inhibitors of TGFβRI/ALK5 for therapeutics of tumors or myelodysplastic syndromes, including LY2157299, EW-7197 and LY3200882, are in the phase Ⅰ to Ⅲ clinical trials, with additional ones inhibiting TGFβRs such as SB-431542, LY2109761, TP-0427736, and IN-1130 being in the preclinical phase. This paper reviews recent advances in research of small-molecule inhibitors targeting TGF-β and its receptors.

TGF-β  /  TGF-β receptor  /  Smad signaling pathway  /  small-molecule inhibitor
Xiao-hong SANG, Hao WANG, Xue-fu YOU, Xin-yi YANG. Research progresses of small molecule inhibitors targeting TGF-β and its receptors[J]. Acta Pharmaceutica Sinica, 2019 , 54 (9) : 1538 -1546 . DOI: 10.16438/j.0513-4870.2019-0132
Year 2019 volume 54 Issue 9
PDF
197
87
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2019-0132
  • Receive Date:2019-02-22
  • Online Date:2026-01-26
  • Published:2019-09-12
Article Data
Affiliations
History
  • Received:2019-02-22
  • Revised:2019-03-28
Funding
Affiliations
    1. Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
    2. School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2019-0132
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT